BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND EML4, ENSG00000143924, 27436
6 results:

  • 1. uterine Sarcoma With eml4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions.
    de Castro JVA; Dos Santos PJS; Mantoan H; Baiocchi G; Bovolim G; Torrezan G; Corassa M; do Nascimento AG; De Brot M; Costa FD; De Brot L
    Int J Gynecol Pathol; 2024 Jan; 43(1):56-60. PubMed ID: 37668341
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. NTRK -Rearranged uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
    Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms.
    Croce S; Hostein I; Longacre TA; Mills AM; PĂ©rot G; Devouassoux-Shisheboran M; Velasco V; Floquet A; Guyon F; Chakiba C; Querleu D; Khalifa E; Mayeur L; Rebier F; Leguellec S; Soubeyran I; McCluggage WG
    Mod Pathol; 2019 Jul; 32(7):1008-1022. PubMed ID: 30877273
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/eml4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.
    Schmoeckel E; Hofmann S; Fromberger D; Rottmann M; Luthardt B; Burges A; Jeschke U; Kirchner T; Lax SF; Mayr D
    Virchows Arch; 2019 May; 474(5):599-608. PubMed ID: 30734108
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Endometrial cancer with an
    Craig JW; Quade BJ; Muto MG; MacConaill LE
    Cold Spring Harb Mol Case Stud; 2018 Aug; 4(4):. PubMed ID: 30068733
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers.
    Xiang L; Li J; Jiang W; Shen X; Yang W; Wu X; Yang H
    Oncotarget; 2015 Mar; 6(7):4968-75. PubMed ID: 25669975
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.